For decades, cannabis breeders grew the plant that everyone profits from. They selected, stabilized and preserved genetics under prohibition, often at real personal risk. Then legalization arrived, and much of that work was absorbed into the commercial market with little credit, less consent and almost no compensation.
Strains were renamed. Lineage was blurred. Provenance became a marketing suggestion rather than a fact.
Now, a new initiative is trying to formalize something the culture has long argued for but rarely enforced: if you use a breeder’s genetics, you ask permission, you give credit and you pay them.
That idea sits at the heart of a new program launched by Arcana Collective, which recently introduced what it calls the PAC framework. PAC stands for Permission, Acknowledgement and Compensation, and while it arrives via a company announcement, the idea itself cuts much deeper than any single brand.
At stake is a question that growers, breeders and even consumers increasingly care about. Who owns cannabis genetics, and who gets to benefit from them?
Why breeders have been easy to ignore
Cannabis genetics sit in a strange legal gray zone. Because the plant remained federally illegal for so long, traditional intellectual property protections were either unavailable or meaningless. Breeders relied on reputation, trust and community norms rather than contracts or courts.
When legal markets emerged, those informal protections collapsed. Genetics moved faster than the people who created them. Cuts changed hands. Seeds circulated. Commercial operators often treated elite genetics as raw material rather than authored work.
For growers, this created a familiar frustration. You could buy a cut called one thing in one state and another thing somewhere else. Claims of authenticity were hard to verify. And the people who actually created those plants were often invisible.
What PAC actually tries to do
The …
Read More
Author: Javier Hasse / High Times
